Direct Thrombin Inhibitors

被引：15

作者：

O'Brien, P. Joshua ^{[1
]}

Mureebe, Leila ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Dept Surg, Vasc Surg Sect, Durham, NC 27710 USA

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS | 2012年 / 17卷 / 01期

关键词：

thrombosis; pathophysiology; TOTAL HIP-REPLACEMENT; ECARIN CLOTTING TIME; HEPARIN-INDUCED THROMBOCYTOPENIA; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; DABIGATRAN ETEXILATE; KNEE REPLACEMENT; DOUBLE-BLIND; ANTICOAGULANT-THERAPY;

D O I：

10.1177/1074248410395941

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiovascular disease is a leading cause of death and pathologic coagulation plays an integral role in the development, propagation, and intervention of cardiovascular disease. The 2 classic anticoagulants, heparin and vitamin K antagonists, though having served humanity for nearly a century, are both inconvenient and nonspecific. Through both direct and indirect roles, thrombin is essential to coagulation, and makes for a very attractive target in medical intervention of pathologic thrombosis. This article will review the nature of direct thrombin inhibitors, current indications, and ongoing trials.

引用

页码：5 / 11

页数：7

共 50 条

[21] Clinical status of direct thrombin inhibitors
Agnelli, G
Sonaglia, F
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1999, 31 (02) : 97 - 117
[22] Clinical results with direct thrombin inhibitors
Nicolaides, AN
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2002, 32 : 36 - 38
[23] The Research Progress of Direct Thrombin Inhibitors
Sun, Zhi-Gang
Yang-Liu
Zhang, Jin-Mai
Cui, Shi-Chang
Zhang, Zhi-Gang
Zhu, Hai-Liang
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (16) : 1574 - 1585
[24] New anticoagulants - direct thrombin inhibitors
Brand, Brigitte
Graf, Lukas
THERAPEUTISCHE UMSCHAU, 2012, 69 (11) : 643 - 649
[25] Direct thrombin inhibitors in cardiac disease
Jeffrey I. Weitz
Eric R. Bates
Cardiovascular Toxicology, 2003, 3 (1) : 13 - 25
[26] Direct thrombin inhibitors in cardiovascular disease
Arsenault, Kyle A.
Hirsh, Jack
Whitlock, Richard P.
Eikelboom, John W.
NATURE REVIEWS CARDIOLOGY, 2012, 9 (07) : 402 - 414
[27] Monitoring direct thrombin inhibitors with a plasma diluted thrombin time
Love, Jason E.
Ferrell, Chris
Chandler, Wayne L.
THROMBOSIS AND HAEMOSTASIS, 2007, 98 (01) : 234 - 242
[28] Development of direct thrombin inhibitors in comparison with glycosaminoglycans
Markwardt, F
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2001, 27 (05): : 523 - 530
[29] SYNTHESIS AND INVESTIGATION OF NOVEL DIRECT THROMBIN INHIBITORS
Girnys, E.
Williams, K.
Mosberg, H.
BIOPOLYMERS, 2009, 92 (04) : 327 - 328
[30] Direct thrombin inhibitors as adjuncts to thrombolytic therapy
French J.K.
White H.D.
Current Cardiology Reports, 1999, 1 (3) : 184 - 191

← 1 2 3 4 5 →